Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

doi:10.1084/jem.179.3.985

This Article

	Full Text (PDF, 757K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Benzaquen, L. R.
	Articles by Halperin, J. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Benzaquen, L. R.
	Articles by Halperin, J. A.


Social Bookmarking

	What's this?

ARTICLES

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

LR Benzaquen, A Nicholson-Weller and JA Halperin
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Interactions between endothelium and vascular smooth muscle cells play a major role in the biology of the blood vessel wall. Growth factors released from endothelial cells control in part the normal and pathological proliferation of vascular smooth muscle cells. Endothelial deposits of C5b-9 proteins, the membrane attack complex of complement (MAC), have been found in a variety of pathological tissues in which cell proliferation is an early characteristic abnormality, including atherosclerosis. We have explored a possible bridging role for terminal complement C5b-9 proteins in eliciting focal signals for cell proliferation by releasing growth factors from endothelial cells. We found that both bovine aortic and human umbilical vein cells respond to the MAC by releasing basic fibroblast growth factor and platelet- derived growth factor. These mitogens stimulate DNA synthesis in Swiss 3T3, vascular smooth muscle, and glomerular mesangial cells. Based on these findings, we propose that complement-induced release of mitogens from endothelial cells is a novel pathogenic mechanism for proliferative disorders.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Kinderlerer, A. R., Ali, F., Johns, M., Lidington, E. A., Leung, V., Boyle, J. J., Hamdulay, S. S., Evans, P. C., Haskard, D. O., Mason, J. C. (2008). KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE. J. Biol. Chem. 283: 14636-14644 [Abstract] [Full Text]
Szabo, A., Laki, J., Madsen, H. O., Dosa, E., Prohaszka, Z., Rugonfalvi-Kiss, S., Kokai, M., Acsadi, G., Karadi, I., Entz, L., Selmeci, L., Romics, L., Fust, G., Garred, P., Cervenak, L. (2007). Early Rise in Serum VEGF and PDGF Levels Predisposes Patients With a Normal MBL2 Genotype to Restenosis After Eversion Endarterectomy. Stroke 38: 2247-2253 [Abstract] [Full Text]
Wehner, J., Morrell, C. N., Reynolds, T., Rodriguez, E. R., Baldwin, W. M. III (2007). Antibody and Complement in Transplant Vasculopathy. Circ. Res. 100: 191-203 [Abstract] [Full Text]
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C. L., Morgan, B. P., Bora, P. S. (2007). CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration. J. Immunol. 178: 1783-1790 [Abstract] [Full Text]
Fosbrink, M., Niculescu, F., Rus, V., Shin, M. L., Rus, H. (2006). C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1. J. Biol. Chem. 281: 19009-19018 [Abstract] [Full Text]
Pickering, M. C., Warren, J., Rose, K. L., Carlucci, F., Wang, Y., Walport, M. J., Cook, H. T., Botto, M. (2006). Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc. Natl. Acad. Sci. USA 103: 9649-9654 [Abstract] [Full Text]
Tinckam, K. J., Chandraker, A. (2006). Mechanisms and Role of HLA and non-HLA Alloantibodies. CJASN 1: 404-414 [Abstract] [Full Text]
Grehan, J. F., Levay-Young, B. K., Fogelson, J. L., Francois-Bongarcon, V., Benson, B. A., Dalmasso, A. P. (2005). IL-4 and IL-13 Induce Protection of Porcine Endothelial Cells from Killing by Human Complement and from Apoptosis through Activation of a Phosphatidylinositide 3-Kinase/Akt Pathway. J. Immunol. 175: 1903-1910 [Abstract] [Full Text]
Bora, P. S., Sohn, J.-H., Cruz, J. M. C., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., Bora, N. S. (2005). Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization. J. Immunol. 174: 491-497 [Abstract] [Full Text]
Bossi, F., Fischetti, F., Pellis, V., Bulla, R., Ferrero, E., Mollnes, T. E., Regoli, D., Tedesco, F. (2004). Platelet-Activating Factor and Kinin-Dependent Vascular Leakage as a Novel Functional Activity of the Soluble Terminal Complement Complex. J. Immunol. 173: 6921-6927 [Abstract] [Full Text]
Qin, X., Goldfine, A., Krumrei, N., Grubissich, L., Acosta, J., Chorev, M., Hays, A. P., Halperin, J. A. (2004). Glycation Inactivation of the Complement Regulatory Protein CD59: A Possible Role in the Pathogenesis of the Vascular Complications of Human Diabetes. Diabetes 53: 2653-2661 [Abstract] [Full Text]
Turnberg, D., Botto, M., Lewis, M., Zhou, W., Sacks, S. H., Morgan, B. P., Walport, M. J., Cook, H. T. (2004). CD59a Deficiency Exacerbates Ischemia-Reperfusion Injury in Mice. Am. J. Pathol. 165: 825-832 [Abstract] [Full Text]
Turnberg, D., Botto, M., Warren, J., Morgan, B. P., Walport, Mark. J., Cook, H. T. (2003). CD59a Deficiency Exacerbates Accelerated Nephrotoxic Nephritis in Mice. J. Am. Soc. Nephrol. 14: 2271-2279 [Abstract] [Full Text]
Bao, L., Haas, M., Kraus, D. M., Hack, B. K., Rakstang, J. K., Holers, V. M., Quigg, R. J. (2003). Administration of a Soluble Recombinant Complement C3 Inhibitor Protects Against Renal Disease in MRL/lpr Mice. J. Am. Soc. Nephrol. 14: 670-679 [Abstract] [Full Text]
Hansson, G. K., Libby, P., Schonbeck, U., Yan, Z.-Q. (2002). Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis. Circ. Res. 91: 281-291 [Abstract] [Full Text]
Zwaka, T. P., Manolov, D., Ozdemir, C., Marx, N., Kaya, Z., Kochs, M., Hoher, M., Hombach, V., Torzewski, J. (2002). Complement and Dilated Cardiomyopathy: A Role of Sublytic Terminal Complement Complex-Induced Tumor Necrosis Factor-{alpha} Synthesis in Cardiac Myocytes. Am. J. Pathol. 161: 449-457 [Abstract] [Full Text]
Tran, G. T., Hodgkinson, S. J., Carter, N., Killingsworth, M., Spicer, S. T., Hall, B. M. (2002). Attenuation of Experimental Allergic Encephalomyelitis in Complement Component 6-Deficient Rats Is Associated with Reduced Complement C9 Deposition, P-Selectin Expression, and Cellular Infiltrate in Spinal Cords. J. Immunol. 168: 4293-4300 [Abstract] [Full Text]
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., Salmon, J. E. (2002). Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss. JEM 195: 211-220 [Abstract] [Full Text]
Badea, T., Niculescu, F., Soane, L., Fosbrink, M., Sorana, H., Rus, V., Shin, M. L., Rus, H. (2002). RGC-32 Increases p34CDC2 Kinase Activity and Entry of Aortic Smooth Muscle Cells into S-phase. J. Biol. Chem. 277: 502-508 [Abstract] [Full Text]
Dobrina, A., Pausa, M., Fischetti, F., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., Tedesco, F. (2002). Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99: 185-192 [Abstract] [Full Text]
MAUIYYEDI, S., PELLE, P. D., SAIDMAN, S., COLLINS, A. B., PASCUAL, M., TOLKOFF-RUBIN, N. E., WILLIAMS, W. W., COSIMI, A. B., SCHNEEBERGER, E. E., COLVIN, R. B. (2001). Chronic Humoral Rejection: Identification of Antibody-Mediated Chronic Renal Allograft Rejection by C4d Deposits in Peritubular Capillaries. J. Am. Soc. Nephrol. 12: 574-582 [Abstract] [Full Text]
Qian, Y.-M., Qin, X., Miwa, T., Sun, X., Halperin, J. A., Song, W.-C. (2000). Identification and Functional Characterization of a New Gene Encoding the Mouse Terminal Complement Inhibitor CD59. J. Immunol. 165: 2528-2534 [Abstract] [Full Text]
Acosta, J., Hettinga, J., Fluckiger, R., Krumrei, N., Goldfine, A., Angarita, L., Halperin, J. (2000). Molecular basis for a link between complement and the vascular complications of diabetes. Proc. Natl. Acad. Sci. USA 97: 5450-5455 [Abstract] [Full Text]
Rhoads, D. N., Eskin, S. G., McIntire, L. V. (2000). Fluid Flow Releases Fibroblast Growth Factor-2 From Human Aortic Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio. 20: 416-421 [Abstract] [Full Text]
Soane, L., Rus, H., Niculescu, F., Shin, M. L. (1999). Inhibition of Oligodendrocyte Apoptosis by Sublytic C5b-9 Is Associated with Enhanced Synthesis of Bcl-2 and Mediated by Inhibition of Caspase-3 Activation. J. Immunol. 163: 6132-6138 [Abstract] [Full Text]
Mason, J. C., Yarwood, H., Sugars, K., Morgan, B. P., Davies, K. A., Haskard, D. O. (1999). Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition. Blood 94: 1673-1682 [Abstract] [Full Text]
Zhang, R. L., Zhang, Z. G., Chopp, M., Zivin, J. A. (1999). Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain � Editorial Comment. Stroke 30: 624-629 [Abstract] [Full Text]
Badea, T. C., Niculescu, F. I., Soane, L., Shin, M. L., Rus, H. (1998). Molecular Cloning and Characterization of RGC-32, a Novel Gene Induced by Complement Activation�in�Oligodendrocytes. J. Biol. Chem. 273: 26977-26981 [Abstract] [Full Text]
Makrides, S. C. (1998). Therapeutic Inhibition of the Complement System. Pharmacol. Rev. 50: 59-88 [Abstract] [Full Text]
Torzewski, M., Torzewski, J., Bowyer, D. E., Waltenberger, J., Fitzsimmons, C., Hombach, V., Gabbert, H. E. (1997). Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell {alpha}-Actin in Early Atherosclerotic Lesions. Arterioscler. Thromb. Vasc. Bio. 17: 2448-2452 [Abstract] [Full Text]
Tedesco, F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., Dobrina, A. (1997). The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity. JEM 185: 1619-1628 [Abstract] [Full Text]
Ananyeva, N. M., Tjurmin, A. V., Berliner, J. A., Chisolm, G. M., Liau, G., Winkles, J. A., Haudenschild, C. C. (1997). Oxidized LDL Mediates the Release of Fibroblast Growth Factor-1. Arterioscler. Thromb. Vasc. Bio. 17: 445-453 [Abstract] [Full Text]
Cheng, G. C., Briggs, W. H., Gerson, D. S., Libby, P., Grodzinsky, A. J., Gray, M. L., Lee, R. T. (1997). Mechanical Strain Tightly Controls Fibroblast Growth Factor-2 Release From Cultured Human Vascular Smooth Muscle Cells. Circ. Res. 80: 28-36 [Abstract] [Full Text]
Torzewski, J., Oldroyd, R., Lachmann, P., Fitzsimmons, C., Proudfoot, D., Bowyer, D. (1996). Complement-Induced Release of Monocyte Chemotactic Protein-1 From Human Smooth Muscle Cells : A Possible Initiating Event in Atherosclerotic Lesion Formation. Arterioscler. Thromb. Vasc. Bio. 16: 673-677 [Abstract] [Full Text]
Stahl, G. L., Reenstra, W. R., Frendl, G. (1995). Complement-Mediated Loss of Endothelium-Dependent Relaxation of Porcine Coronary Arteries : Role of the Terminal Membrane Attack Complex. Circ. Res. 76: 575-583 [Abstract] [Full Text]
Russo, K., Ragone, R., Facchiano, A. M., Capogrossi, M. C., Facchiano, A. (2002). Platelet-derived Growth Factor-BB and Basic Fibroblast Growth Factor Directly Interact in Vitro with High Affinity. J. Biol. Chem. 277: 1284-1291 [Abstract] [Full Text]